Table of Contents
<< Previous Issue | May 2008 (Vol: 2008, Issue: 96) | Next Issue >> |
- Section: Business Commentaries
-
The Next Generation PharmaDeals
- Section: Licensing
-
Sepracor Enters into Multiple Deals with Arrow
-
KAI Pharmaceuticals' Candidate Get Second Chance
-
Pfizer Continues Its Biologics Focused Deal-Making
-
Lundbeck Gains European Rights for Alzheimer’s Drug
- Section: Mergers & Acquisitions
-
Needle-free Vaccines Lead Intercell to the US with its Latest Acquisition
-
Antisoma's Shares Rise as Company Announces Acquisition of Xanthus
-
Daiichi Sankyo Boosts Oncology Portfolio with Acquisition of Biotech, U3 Pharma
-
Sonus Finds Way Out through Merger with OncoGenex
-
BMS Bags a Bargain
- Section: Research & Development
-
Ranbaxy and Merck & Co. Team Up To Develop Novel Anti-Infectives
-
Alnylam and Takeda Form RNAi Partnership